US exporters suffering in Argentina
This article was originally published in Clinica
US medtech exports to Argentina have fallen over 20% since 1994 to $74 million. Exporters face stiff competition from local industry and several emerging-nation exporters, says industry association HIMA. Local companies account for between 25 and 30% of the market, with the US holding a 35% share and the remainder comprising products from Germany, Japan, Brazil, Thailand and South Korea.
You may also be interested in...
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Among the largest gaps in safety data is non-clinical research on CBD use's effect on developing fetus and adolescent brain, in utero/lactational exposure, reproductive toxicity and the potential for a latency period before toxicity, says FDA neuroscientist Andrew Shen.
The templates from the US agency provide guidance to manufacturers developing antibody tests for clinical or at-home use.